Pulmonary arterial hypertension: Newer treatments are improving outcomes

Wayne State University

Kasem Sirithanakul, MD； Kamal K. Mubarak, MD     发表于2004年

. Echocardiography is useful for screening high-risk patients (SOR: A). . The New York Heart Association classification of dyspnea has been modified by the World Health Organization to categorize pulmonary hypertension by the severity of symptoms, which, unlike pulmonary arterial pressure, correlates well with survival (SOR: A). . Calcium channel blockers are useful only for patients who respond to vasodilator testing in a cardiac catheterization laboratory (SOR: A). . Therapeutic modalities now include parenteral prostanoids, oral endothelin receptor antagonists, PDE5 inhibitors, and lung transplantation (SOR: A; for PDE5 inhibitors, SOR: B) . Early referral to expert centers is crucial to patient survival (SOR: B)....查看全文